Panacea Life Sciences Holdings, Inc. – OTC:PLSH

Add to watchlist

$0.051

-0.01

-17.21%

Market closed

Open in about 20 hours

-20.05%

month

-20.05%

quarter

-72.27%

year

Market Cap	3.66M
Enterprise value	11.21M

P/E	-0.57
EV/Sales	4.37
EV/EBITDA	-1.50
Price/Sales	2.39
Price/Book	-2.86
PEG ratio	N/A
EPS	-0.45

Revenue	2.76M
EBITDA	-3.55M
Income	-7.67M
Revenue Q/Q	55.93%
Revenue Y/Y	50.37%

Profit margin	-541.83%
Oper. margin	-333.22%
Gross margin	24.77%
EBIT margin	-333.22%
EBITDA margin	-128.68%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Profit margin
Jun 2023	399.12K	-1.86M	-467.08%
Sep 2023	347.85K	-2.15M	-618.39%
Dec 2023	960.49K	-2.20M	-229.95%
Mar 2024	1.05M	-1.44M	-136.88%

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Payout ratio
Payout ratio	0%

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Dividend Yield
2019	106.72%
2020
2021
2022
2023

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Debt to assets
Jun 2023	17853879	23.42M	131.18%
Sep 2023	18732569	24.81M	132.47%
Dec 2023	17983462	26.27M	146.11%
Mar 2024	17412545	27.03M	155.26%

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Cash Flow
Jun 2023	-483.31K	-9.35K	427.62K
Sep 2023	-728.86K	-22.84K	745.02K
Dec 2023	1.57K	-17.90K	115.75K
Mar 2024	-357.09K	-5K	368.81K

Panacea Life Sciences Holdings alternative data

Panacea Life Sciences Holdings
Employees

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Employee count
Aug 2023	19
Sep 2023	19
Oct 2023	19
Nov 2023	19
Dec 2023	19
Jan 2024	19
Feb 2024	19
Mar 2024	19
Apr 2024	19
May 2024	40
Jun 2024	40
Jul 2024	40

Panacea Life Sciences Holdings
Insider Trading

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Insider trades (number of shares)
Period	Buy	Sel
Nov 2022	5000	0
Dec 2022	1000	0
Feb 2023	4000	0
Apr 2023	16700	0
May 2023	21800	0
Jun 2023	3000	0
Sep 2023	20000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	18 Sep 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	20,000	$0.24	$4,740
Purchase	9 Jun 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	3,000	$0.43	$1,299
Purchase	23 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	500	$0.5	$249
Purchase	19 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	4,500	$0.51	$2,295
Purchase	19 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	1,500	$0.52	$780
Purchase	9 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	2,300	$0.38	$867
Purchase	8 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	1,500	$0.43	$645
Purchase	5 May 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	11,500	$0.49	$5,635
Purchase	26 Apr 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	5,500	$0.4	$2,189
Purchase	25 Apr 2023	BUTTORFF LESLIE director, 10 percent owner, officer: CEO director, 10 percent owner, off..	Common Stock	1,000	$0.32	$320

PLSH insider trading transactions

Panacea Life Sciences Holdings
Latest News

Thursday, 16 May 2024
09:15	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	globenewswire.com

Frequently Asked Questions (FAQ)

What's the price of Panacea Life Sciences Holdings stock today?

One share of Panacea Life Sciences Holdings stock can currently be purchased for approximately $0.05.
When is Panacea Life Sciences Holdings's next earnings date?

Unfortunately, Panacea Life Sciences Holdings's (PLSH) next earnings date is currently unknown.
Does Panacea Life Sciences Holdings pay dividends?

No, Panacea Life Sciences Holdings does not pay dividends.
How much money does Panacea Life Sciences Holdings make?

Panacea Life Sciences Holdings has a market capitalization of 3.66M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 46.59% to 2.38M US dollars.
What is Panacea Life Sciences Holdings's stock symbol?

Panacea Life Sciences Holdings, Inc. is traded on the OTC under the ticker symbol "PLSH".
What is Panacea Life Sciences Holdings's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
How do i buy shares of Panacea Life Sciences Holdings?

Shares of Panacea Life Sciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Panacea Life Sciences Holdings have?

As Jul 2024, Panacea Life Sciences Holdings employs 40 workers, which is 111% more then previous quarter.
What is Panacea Life Sciences Holdings's official website?

The official website for Panacea Life Sciences Holdings is panacealife.com.
Where are Panacea Life Sciences Holdings's headquarters?

Panacea Life Sciences Holdings is headquartered at 5910 South University Boulevard, Greenwood Village, CO.
How can i contact Panacea Life Sciences Holdings?

Panacea Life Sciences Holdings's mailing address is 5910 South University Boulevard, Greenwood Village, CO and company can be reached via phone at +800 9850515.

Panacea Life Sciences Holdings, Inc.

panacealife.com

Exchange:

OTC

Full time employees:

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.

+800 9850515

5910 South University Boulevard
Greenwood Village, CO 80121

CIK: 0001552189
:
: